Find a Tender
complete
Official procurement procedure
PROVISIONS OF PCR MASTER MIXES – CLONALITY TESTING
No classification published
Location not published
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Cardiff and Vale University Health Board: "PROVISIONS OF PCR MASTER MIXES – CLONALITY TESTING". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Cardiff and Vale University Health Board | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Cardiff and Vale University Health Board
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Cardiff and Vale University Health Board. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
3.3Bids / Report
Supplier ConcentrationModerate Concentration
Cardiff CouncilTop vendor: 32.1% of attributable valuePayment Terms
Check noticePublished terms
Coverage: 44 active published awards; 3 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
| Supplier Name | Historic Awards | Attributable GBP Value |
|---|---|---|
| Cardiff Council | 3 wins | £167,962 |
| Vale of Glamorgan Council | 2 wins | £105,800 |
| Northstar Healthcare Consultancy Ltd | 1 win | £93,000 |
| Mel Research | 1 win | £81,600 |
| Cardiff Marriott Hotel | 1 win | £43,516 |
Procedure terms
Contracting AuthorityCardiff and Vale University Health Board | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published4 Jun 2026, 16:22 BST | Last source update4 Jun 2026, 16:22 BST | Recurring procurementNot published |
ClassificationNot published | ||
Delivery areaLocation not published | ||
OCIDocds-h6vhtk-05ecf5 | ||
What is being bought
The All Wales Medical Genomics Service (AWMGS) is awarding a direct contract for the supply of PCR mastermixes and associated reagents required for B and T cell clonality testing. These assays are critical for diagnosing and monitoring haematological malignancies such as lymphoma and must include validated clonal and polyclonal controls, as well as a control gene, to ensure accurate and reproducible results. In addition to product supply, the contract includes technical support to maintain continuity of service. Changing supplier would require extensive revalidation and re-accreditation of all assays, which would be a major undertaking and cause significant disruption to diagnostic services. This would lead to delays in patient testing, risking late or missed diagnoses and potentially endangering patient health and outcomes. The direct award is therefore essential to safeguard patient safety, maintain compliance with UKAS standards, and ensure uninterrupted delivery of critical genomic testing services across Wales
What changed
From the official release history
- Official notice release published
4 Jun 2026, 16:22 BST - Official notice release published
2 Dec 2025, 14:36 GMT - Status changed to complete
2 Dec 2025, 13:45 GMT - Official notice release published
2 Dec 2025, 13:45 GMT - Buyer information updated
2 Dec 2025, 13:45 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
4 Jun 2026, 16:22 BST - Award active
Not published · Not published - Contract active
Signed 31 Mar 2026, 00:00 BST · £108,316
Commercial outcome and competition
Awards Invivoscribe technologies SARL Not published · Not published · active |
Contracts PROVISIONS OF PCR MASTER MIXES – CLONALITY TESTING £108,316 · signed 31 Mar 2026, 00:00 BST · active Contract period: 31 Mar 2026, 00:00 BST — 31 Dec 2026, 23:59 GMT |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
Cardiff and Vale University Health Board
Contracting authority GB-PPON-PPPR-7969-BTJGDocuments (1)
Official links; attachments are not copied
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleThe requirement relates to a highly specialised product/service where only a limited number of suppliers in the market can meet the necessary technical and clinical requirements. The selected supplier provides a defined solution that is compatible with existing systems and meets specific performance standards. Due to these technical constraints and the need for continuity of service, no alternative supplier is capable of delivering the required specification without significant disruption or risk |